Mar 31, 2015 | Inside, Neuroscience, Research
New research at the Icahn School of Medicine at Mount Sinai sheds light for the first time on how depression and emotional resilience operate on a molecular level. The findings, published in the December 4, 2014, issue of Nature, bring fresh perspective to an area that has eluded researchers for decades by outlining the mechanisms within cells that activate depression and laying the groundwork for new treatments. Current drugs for depression focus on neurotransmitters, or communication between cells, but identification of this novel biochemical pathway could pave the way for more effective drugs with very different mechanisms. (more…)
May 14, 2014 | Social Work
Depression. Bipolar disorder. Anxiety disorders. Post traumatic stress. Addiction. These are illnesses that are misunderstood by many and are surrounded by stigma. The negative perceptions that people have are far from reality. The fact is, these are real, treatable medical conditions just like diabetes or heart disease. They are not weaknesses or character flaw
(more…)
Updated on Jun 30, 2022 | Inside, Neuroscience, Research, School
Ketamine, a drug approved for use as a general anesthetic and sedative, also appears to provide significant relief to patients with major depressive disorder, and those with chronic post-traumatic stress disorder (PTSD), according to two separate studies conducted by researchers at Icahn School of Medicine at Mount Sinai.
(more…)
Nov 27, 2013 | Exercise, Health Tips
This post was adapted from information that originally appeared on www.LiveWellNewYork.com
As we head into winter, the days are growing shorter, the weather is getting colder—and many people are bracing for the blues. It’s not uncommon to feel down around the winter holidays, so try the following tips to help lift your mood and fight off seasonal depression. (more…)
Nov 4, 2013 | Health Tips, Holistic Health
Guest post by Abigail Strubel, MA, LCSW
Many people might feel a bit glum during the cold, dark winter months, but when that sadness deepens into actual depression, it is known as Seasonal Affective Disorder (SAD). (more…)
New research at the Icahn School of Medicine at Mount Sinai sheds light for the first time on how depression and emotional resilience operate on a molecular level. The findings, published in the December 4, 2014, issue of Nature, bring fresh perspective to an area that has eluded researchers for decades by outlining the mechanisms within cells that activate depression and laying the groundwork for new treatments. Current drugs for depression focus on neurotransmitters, or communication between cells, but identification of this novel biochemical pathway could pave the way for more effective drugs with very different mechanisms. (more…)
